Nifeviroc
Nifeviroc (TD-0232) is an orally bioavailable small molecule antagonist of the CCR5 chemokine receptor. It is utilized in HIV-1 research to investigate viral entry inhibition and has been employed in both in vitro antiviral assays and in vivo preclinical studies of HIV-1 infection.
Product Specifications
CAS Number
934740-33-7
Product Name Alternative
Nifeviroc, TD 0232, TD0232, TD-0232
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
98.14% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.59 mM) ; H2O:80 mg/mL (135.43 mM) ; DMSO:80 mg/mL (135.43 mM)
Smiles
O[C@@]1 (C2=CC=CC=C2) [C@H] (CN (C1) C (C3CCCC3) =O) CN4CCC (CC4) N (CC=C) C (OCC5=CC=C (C=C5) [N+] ([O-]) =O) =O
Molecular Formula
C33H42N4O6
Molecular Weight
590.71
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
InVivoMAb Anti-Human TREML1/TLT1 Antibody (Iv0130)
InVivoMAb Anti-Human TREML1/TLT1 Antibody (Iv0130)